Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.82%204.43M | -1.12%194.82M | -3.47%201.71M | 5.46%786.92M | 3.89%225.93M | 8.44%202.77M | 11.15%197.04M | 10.95%208.96M | -3.46%746.2M | 19.97%217.47M |
| Cost of revenue | -2.53%145.02M | 4.22%137.15M | 2.46%143.28M | 5.01%552.51M | -6.44%158.2M | 9.73%148.78M | 12.01%131.59M | 12.69%139.85M | 3.01%526.14M | 44.90%169.09M |
| Gross profit | 10.04%59.41M | -11.88%57.67M | -15.47%58.42M | 6.52%234.41M | 39.99%67.73M | 5.06%53.99M | 9.47%65.45M | 7.57%69.11M | -16.07%220.06M | -25.08%48.38M |
| Operating expense | 12.36%16.42M | 8.26%15.42M | 52.49%15.03M | 7.21%37.32M | -0.05%18.2M | -27.17%14.62M | 43.54%14.25M | -1.12%9.86M | 103.33%34.81M | 189.69%18.21M |
| Staff costs | ---- | ---- | ---- | -4.25%16.77M | ---- | ---- | ---- | ---- | 603.49%17.52M | ---- |
| Selling and administrative expenses | 13.86%14.07M | 21.17%13.07M | 19.48%9.08M | 11.79%6.29M | 14.19%15.83M | -31.21%12.36M | 37.56%10.79M | -3.64%7.6M | 9.23%5.62M | 152.38%13.86M |
| -General and administrative expense | 13.86%14.07M | 21.17%13.07M | 19.48%9.08M | 11.79%6.29M | 14.19%15.83M | -31.21%12.36M | 37.56%10.79M | -3.64%7.6M | 9.23%5.62M | 152.38%13.86M |
| Rent and land expenses | ---- | ---- | ---- | 382.67%5.13M | ---- | ---- | ---- | ---- | 41.41%1.06M | ---- |
| Other operating expenses | 4.16%2.35M | -32.02%2.35M | 163.62%5.95M | -13.87%9.14M | -45.49%2.37M | 7.32%2.26M | 66.04%3.46M | 8.41%2.26M | 21.51%10.61M | 48.51%4.34M |
| Operating profit | 9.18%42.99M | -17.48%42.25M | -26.77%43.4M | 6.39%197.09M | 64.15%49.53M | 25.70%39.38M | 2.69%51.2M | 9.17%59.26M | -24.42%185.24M | -64.45%30.17M |
| Net non-operating interest income (expenses) | 26.34%-4.25M | 25.52%-4.87M | 24.86%-5.32M | 32.73%-24.47M | -127.71%-5.07M | -988.46%-5.78M | 75.25%-6.54M | 75.51%-7.08M | 24.79%-36.38M | 288.57%18.31M |
| Non-operating interest income | -0.13%9.43M | 2.74%9.37M | 5.99%9.27M | 28.18%2.92M | -46.72%9.75M | 5.43%9.44M | 9.09%9.12M | 14.99%8.75M | 26.60%2.28M | 267.58%18.31M |
| Non-operating interest expense | -10.07%13.69M | -9.06%14.24M | -7.81%14.59M | -14.85%60.15M | --14.83M | 83.19%15.22M | -54.97%15.66M | -56.66%15.83M | 5.29%70.65M | ---- |
| Total other finance cost | ---- | ---- | ---- | -2.41%-32.77M | ---- | ---- | ---- | ---- | -88.97%-31.99M | ---- |
| Net investment income | 50.15%18.24M | 56.31%12.15M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -92.45%588K | 70,945.45%7.79M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 9,990.00%2.97M | 99.73%-30K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | -10,016.67%-2.98M | ---- | ---- | ---- | ---- | -99.68%30K | ---- |
| Less:Write off | ---- | ---- | ---- | --8K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 17.51%8.21M | -14.23%6.8M | -23.30%4.36M | 152.33%5.17M | -46.92%2.89M | -45.45%6.99M | 55.03%7.93M | -9.46%5.68M | 34.83%-9.88M | 122.56%5.44M |
| Income before tax | 15.67%46.95M | -15.99%44.18M | -26.66%42.43M | 25.60%199.58M | -12.19%47.34M | -9.37%40.59M | 84.17%52.59M | 82.86%57.86M | -10.74%158.9M | 13.46%53.92M |
| Income tax | 17.43%14.73M | -25.92%9.44M | 6.86%14.05M | 36.23%46.1M | -14.75%6.46M | 2.05%12.54M | 165.20%12.75M | 43.52%13.15M | -32.71%33.84M | -35.83%7.58M |
| Net income | 14.88%32.22M | -12.82%34.74M | -36.52%28.38M | 22.73%153.48M | -11.77%40.88M | -13.69%28.05M | 67.77%39.85M | 98.89%44.71M | -2.08%125.06M | 29.76%46.34M |
| Net income continuous operations | 14.88%32.22M | -12.82%34.74M | -36.52%28.38M | 22.73%153.48M | -11.77%40.88M | -13.69%28.05M | 67.77%39.85M | 98.89%44.71M | -2.08%125.06M | 29.76%46.34M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 14.88%32.22M | -12.82%34.74M | -36.52%28.38M | 22.73%153.48M | -11.77%40.88M | -13.69%28.05M | 67.77%39.85M | 98.89%44.71M | -2.08%125.06M | 29.76%46.34M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 14.88%32.22M | -12.82%34.74M | -36.52%28.38M | 22.73%153.48M | -11.77%40.88M | -13.69%28.05M | 67.77%39.85M | 98.89%44.71M | -2.08%125.06M | 29.76%46.34M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 14.75%0.07 | -12.82%0.0755 | -36.52%0.0617 | 22.73%0.3337 | -11.72%0.0889 | -13.60%0.061 | 67.83%0.0866 | 98.77%0.0972 | -2.09%0.2719 | 29.60%0.1007 |
| Diluted earnings per share | 14.75%0.07 | -12.82%0.0755 | -36.52%0.0617 | 22.73%0.3337 | -11.72%0.0889 | -13.60%0.061 | 67.83%0.0866 | 98.77%0.0972 | -2.09%0.2719 | 29.71%0.1007 |
| Dividend per share | -25.00%0.03 | 0.00%0.03 | 66.67%0.05 | 8.33%0.13 | 0.00%0.03 | 33.33%0.04 | 0.00%0.03 | 0.00%0.03 | -14.29%0.12 | 0.00%0.03 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.